Literature DB >> 3473066

Morphology of pulmonary metastases from osteosarcoma during chemotherapy.

T Derstappen, A Roessner, K M Müller, E Grundmann.   

Abstract

Osteosarcoma is known to metastasize rather early, and even after surgical resection of the primary metastases may occur predominantly in the lung. Administration of polychemotherapy for destruction of micrometastases has served to improve prognosis. Preoperative chemotherapy facilitates the evaluation of regression, another factor of high prognostic relevance. Morphologic analysis of pulmonary metastases developing during chemotherapy is of considerable interest on account of the potential therapy resistance of certain histologic subtypes of osteosarcoma. In the present study pulmonary metastases resected in 20 thoracotomies of 15 osteosarcoma patients were investigated by light microscopy and compared, if possible, to the respective primaries. All patients had received chemotherapy, predominantly according to the COSS 80 and COSS 82 protocols. The histologic picture of a tumor was found to change from the primary to the pulmonary metastasis, a pattern also verified in the lung metastases collected in consecutive thoracotomies from the same patient. Several different subtypes were regularly found side by side in the metastases, but generally no special sensitivity or resistance to chemotherapy could be attributed to any of these subtypes. Our results nevertheless do indicate an increased resistance of anaplastic tumor tissue. The response to chemotherapy agreed in 9 of 10 primaries with that of their metastases.

Entities:  

Mesh:

Year:  1987        PMID: 3473066     DOI: 10.1007/BF00396380

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  20 in total

1.  Multidrug chemotherapy in pulmonary treatment of osteosarcoma.

Authors:  W W Sutow; E A Gehan; T J Vietti; A E Frias; P G Dyment
Journal:  J Bone Joint Surg Am       Date:  1976-07       Impact factor: 5.284

2.  Combined ultrastructural, histochemical, and autoradiographic study of osteosarcoma after preoperative chemotherapy according to the COSS 80 protocol.

Authors:  E Grundmann; A Roessner; W Schlake; M Immenkamp; P Preusser; G Wüst; J Ritter; E Schnepper
Journal:  J Cancer Res Clin Oncol       Date:  1983       Impact factor: 4.553

3.  Morphological changes in osteosarcoma after chemotherapy--COSS 80.

Authors:  G Delling; H Krumme; M Salzer-Kuntschik
Journal:  J Cancer Res Clin Oncol       Date:  1983       Impact factor: 4.553

4.  Cytostatic effects in osteosarcomas as detected by flow cytometric DNA analysis after preoperative chemotherapy according to the COSS 80/82 protocol.

Authors:  T Bösing; A Roessner; W Hiddemann; W Mellin; E Grundmann
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

5.  [Therapeutic response of various histological osteosarcoma subtypes to high-dose methotrexate treatment].

Authors:  A Schulz; H P Fischer; H Breithaupt; H Pralle
Journal:  Onkologie       Date:  1983-12

6.  Biologic characterization of human bone tumors. II. Distribution of different collagen types in osteosarcoma--a combined histologic, immunofluorescence and electron microscopic study.

Authors:  A Roessner; B Voss; J Rauterberg; M Immenkamp; E Grundman
Journal:  J Cancer Res Clin Oncol       Date:  1983       Impact factor: 4.553

7.  Primary osteogenic sarcoma: eight-year experience with adjuvant chemotherapy.

Authors:  G Rosen; R C Marcove; A G Huvos; B I Caparros; J M Lane; A Nirenberg; A Cacavio; S Groshen
Journal:  J Cancer Res Clin Oncol       Date:  1983       Impact factor: 4.553

8.  Combination chemotherapy and radiation therapy in the treatment of metastatic osteogenic sarcoma.

Authors:  G Rosen; M Tefft; A Martinez; W Cham; M L Murphy
Journal:  Cancer       Date:  1975-03       Impact factor: 6.860

9.  [Combination chemotherapy in osteogenic sarcoma: the Memorial Sloan-Kettering cancer center experience (author's transl)].

Authors:  H Jürgens; G Rosen
Journal:  Klin Padiatr       Date:  1980-03       Impact factor: 1.349

10.  Prognostic factors in osteosarcoma. A review of 20 year's experience at the University of Pittsburgh Health Center Hospitals.

Authors:  P E Scranton; F A DeCicco; R S Totten; E J Yunis
Journal:  Cancer       Date:  1975-12       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.